NCT03216291

Brief Summary

Biofeedback therapy is a labor-intensive, multi-disciplinary, team approach for the management of patients with Fecal Incontinence. It is not easily available to the vast majority of patients in the community with this problem. It is therefore imperative that a more pragmatic therapeutic approach that can be administered easily in the community ought to be developed. However, whether a treatment program that is based on home-training can be just as useful as office-based training has not been evaluated. The purpose of this study is to assess whether having patients train their pelvic floor muscles at home is as effective as in-office biofeedback training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

October 28, 2015

Completed
1.7 years until next milestone

First Posted

Study publicly available on registry

July 13, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
Last Updated

August 6, 2020

Status Verified

August 1, 2020

Enrollment Period

2.4 years

First QC Date

October 28, 2015

Last Update Submit

August 4, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of episodes of fecal incontinence

    Assess the change in the No of FI episodes between baseline week and end of study week and compare between the two treatment groups. Responder is defined as a patient with greater than 50% reduction in FI episodes after treatment when compared to baseline. Responder rates will compared between the two treatment groups.

    six weeks

Secondary Outcomes (4)

  • Overall quality of life and symptom perception on previously validated Fecal Incontinence questionnaires

    six weeks

  • Anal sphincter pressure and rectal sensation

    six weeks

  • FI severity, quality of life and bowel symptoms

    Six weeks

  • Treatment compliance with home biofeedback

    Six weeks

Study Arms (2)

Home Biofeedback

ACTIVE COMPARATOR

Patients will be given home biofeedback device (InTone) to take home and practice biofeedback exercises at least twice a day for six weeks of therapy. Intervention: Home device biofeedback training.

Device: Home Biofeedback therapy

Office biofeedback

ACTIVE COMPARATOR

Patients with fecal incontinence will receive traditional office biofeedback, once weekly, over six weeks. Intervention: Regular office biofeedback training with assistance of biofeedback person..

Behavioral: biofeedback therapy

Interventions

Biofeedback therapy is a labor-intensive, multi-disciplinary, team approach for the management of patients with anorectal problems. Complete training sessions once a week for 6 weeks in the office.

Also known as: Training
Office biofeedback

Biofeedback therapy is a labor-intensive, multi-disciplinary, team approach for the management of patients with anorectal problems, but instead of an office therapy, the subject will use a biofeedback device to gain strength in their anorectal muscles. This device will be taught how to use in the first session and then the subject will take it home to complete at least 1 session a day for 6 weeks.

Home Biofeedback

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • recurrent episodes of fecal incontinence for six months
  • no mucosal disease
  • on a two week stool diary patient will report at least one episode of incontinence a week

You may not qualify if:

  • severe diarrhea
  • on opioids, tricyclics (except on stable doses \> 3months)
  • active depression
  • comorbid illnesses, severe cardiac disease, chronic renal failure or previous gastrointestinal surgery except cholecystectomy and appendectomy
  • neurologic diseases (e.g. head injury, epilepsy, multiple sclerosis, strokes, spinal cord injury)
  • impaired cognizance (mini mental score of \< 15) and/or legally blind
  • metal implants, pacemakers
  • previous pelvic surgery, bladder repair, radical hysterectomy
  • ulcerative and Crohn's colitis
  • rectal prolapse, anal fissure, anal surgery or inflamed hemorrhoids
  • pregnant women or nursing mothers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Augusta University

Augusta, Georgia, 30907, United States

Location

MeSH Terms

Conditions

Fecal Incontinence

Interventions

Biofeedback, Psychology

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Study Officials

  • Satish Rao, MD, PhD

    Augusta University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Everyone is masked to the assignment of home or office biofeedback training. Once the subject makes it to their treatment session, then everyone will know which one the subject has been allocated to.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine, Division Chief Fellowship Program Director Director, Digestive Health Center

Study Record Dates

First Submitted

October 28, 2015

First Posted

July 13, 2017

Study Start

October 1, 2015

Primary Completion

March 1, 2018

Study Completion

September 30, 2019

Last Updated

August 6, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations